Brief Interventions for Drop-out Re-engagement

September 16, 2014 updated by: Yale University

Adaptive Brief Interventions for Drop-out Re-engagement

We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

We propose a 5-year Stage I behavioral therapy development study to: 1) prospectively evaluate risk factors for premature drop-out from outpatient treatment; 2) develop and test a manual of single session phone-and office-based interventions to re-engage these individual in treatment.

Study Type

Interventional

Enrollment (Actual)

299

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Connecticut
      • New Haven, Connecticut, United States, 06510
        • APT Foundation
      • New Haven, Connecticut, United States, 06510
        • Connecticut Mental Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • admission to outpatient treatment

Exclusion Criteria:

  • need for hospitalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard care follow up
Standard care counselor follow up care phone calls or letters.
Behavioral: standard care follow up
routine counselor phone calls and letters
Experimental: Drop out reengagement motivational intervention
Single session office based or phone based motivational counseling session designed to promote participant re-engagement in standard treatment.
Behavioral: brief (behavioral therapy)
up t 3 sessions of phone or office based counseling sessions to promote re-engagement in treatment.
Behavioral: Drop out re-engagement motivational intervention
Up to 3 phone or office based counseling sessions to promote reengagement in treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
retention into outpatient treatment
Time Frame: 4, 8, 12, 24 weeks
4, 8, 12, 24 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
substance abuse
Time Frame: 4, 8,12,and 24 weeks
4, 8,12,and 24 weeks
psychiatric symptoms
Time Frame: 4, 8, 12, and 24 weeks
4, 8, 12, and 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yale University

Investigators

  • Principal Investigator: Sam Ball, PhD, Yale School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2004

Primary Completion (Actual)

November 1, 2009

Study Completion (Actual)

November 1, 2009

Study Registration Dates

First Submitted

July 7, 2006

First Submitted That Met QC Criteria

July 10, 2006

First Posted (Estimate)

July 11, 2006

Study Record Updates

Last Update Posted (Estimate)

September 17, 2014

Last Update Submitted That Met QC Criteria

September 16, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 101010101
  • 5P50DA009241-120012
  • 5P50DA009241 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Clinical Trials on standard care follow up

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe